tiprankstipranks
Trending News
More News >
Ocumension Therapeutics (HK:1477)
:1477
Hong Kong Market

Ocumension Therapeutics (1477) Financial Statements

Compare
1 Followers

Ocumension Therapeutics Financial Overview

Ocumension Therapeutics's market cap is currently HK$6.50B. The company's EPS TTM is HK$-0.18992779440000002; its P/E ratio is -22.35; Ocumension Therapeutics is scheduled to report earnings on August 21, 2025, and the estimated EPS forecast is HK$-0.03. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 417.31M¥ 246.37M¥ 158.96M¥ 56.15M¥ 13.10M
Gross Profit¥ 225.06M¥ 144.37M¥ 102.92M¥ 36.94M¥ 11.37M
Operating Income¥ -306.43M¥ -402.15M¥ -455.86M¥ -385.20M¥ -451.72M
EBITDA¥ -188.03M¥ -320.62M¥ -359.98M¥ -249.81M¥ -2.26B
Net Income¥ -268.27M¥ -379.79M¥ -402.64M¥ -259.99M¥ -2.26B
Balance Sheet
Cash & Short-Term Investments¥ 769.21M¥ 1.05B¥ 1.29B¥ 1.77B¥ 2.03B
Total Assets¥ 3.97B¥ 3.27B¥ 3.04B¥ 3.33B¥ 2.60B
Total Debt¥ 25.78M¥ 137.98M¥ 29.58M¥ 11.21M¥ 7.24M
Net Debt¥ -703.42M¥ -704.86M¥ -1.14B¥ -1.11B¥ -2.03B
Total Liabilities¥ 200.19M¥ 351.03M¥ 295.04M¥ 222.88M¥ 97.23M
Stockholders' Equity¥ 3.77B¥ 2.92B¥ 2.75B¥ 3.11B¥ 2.50B
Cash Flow
Free Cash Flow¥ -408.97M¥ -539.79M¥ -510.66M¥ -861.66M¥ -517.18M
Operating Cash Flow¥ -178.83M¥ -177.93M¥ -200.66M¥ -196.85M¥ -212.57M
Investing Cash Flow¥ 275.91M¥ -259.78M¥ 229.15M¥ -1.35B¥ 629.70M
Financing Cash Flow¥ -213.79M¥ 108.66M¥ -9.22M¥ 668.85M¥ 1.53B
Currency in CNY

Ocumension Therapeutics Earnings and Revenue History

Ocumension Therapeutics Debt to Assets

Ocumension Therapeutics Cash Flow

Ocumension Therapeutics Forecast EPS vs Actual EPS